SEPN 内幕交易
SEPN 的 SEC Form 4 内幕交易记录
总交易
78
买入
0
买入总额
-
卖出总额
$132.9M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(67) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 | 746,500 | $42.50 | $31.7M | 2026-08-12 | 董事卖出, 大股东(>10%)卖出 |
| ★★★★★(43) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 66,363 | $28.14 | $1.9M | 2026-03-02 | 高管卖出, 百万级卖出 |
| ★★★★★(30) | RA CAPITAL HEALTHCARE FUND LP | - | 卖出 | 746,500 | $48.19 | $36.0M | 2026-08-12 | 巨额卖出(>$10M), 非10b5-1计划卖出 |
| ★★★★★(30) | RA CAPITAL NEXUS FUND III, L.P. | - | 卖出 | 746,500 | $48.19 | $36.0M | 2026-08-12 | 巨额卖出(>$10M), 非10b5-1计划卖出 |
| ★★★★★(28) | KIM JAE B. | Chief Medical Officer | 卖出 | 94,339 | $35.26 | $3.3M | 2026-06-22 | 高管卖出, 百万级卖出 |
| ★★★★★(27) | THIRD ROCK VENTURES V, L.P. | - | 卖出 | 147,059 | $50.27 | $7.4M | 2026-08-12 | 大股东(>10%)卖出, 超大额卖出(>$5M) |
| ★★★★★(27) | THIRD ROCK VENTURES V, L.P. | - | 卖出 | 147,200 | $51.00 | $7.5M | 2026-08-12 | 大股东(>10%)卖出, 超大额卖出(>$5M) |
| ★★★★★(25) | BHATT ELIZABETH | President and COO | 卖出 | 25,000 | $44.00 | $1.1M | 2026-08-11 | C-suite卖出, 百万级卖出 |
| ★★★★★(25) | BHATT ELIZABETH | President and COO | 卖出 | 29,000 | $38.85 | $1.1M | 2026-08-11 | C-suite卖出, 百万级卖出 |
| ★★★★★(25) | BHATT ELIZABETH | President and COO | 卖出 | 2,200 | $28.46 | $63K | 2026-02-18 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | BHATT ELIZABETH | President and COO | 卖出 | 1,800 | $29.58 | $53K | 2026-02-18 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(23) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 2,178 | $35.18 | $77K | 2026-06-29 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 6,250 | $35.08 | $219K | 2026-06-12 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 2,889 | $29.66 | $86K | 2026-06-01 | 高管卖出, 减持超50%持仓 |
| ★★★★★(23) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 11,798 | $30.06 | $355K | 2026-05-26 | 高管卖出, 减持超50%持仓 |
| ★★★★★(18) | KIM JAE B. | Chief Medical Officer | 卖出 | 2,438 | $36.61 | $89K | 2026-06-26 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 4,090 | $27.51 | $112K | 2026-03-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 76,388 | $29.02 | $2.2M | 2026-03-02 | 高管卖出, 百万级卖出 |
| ★★★★★(16) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 1,700 | $27.78 | $47K | 2026-06-01 | 高管卖出, 减持超20%持仓 |
| ★★★★★(16) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 1,346 | $28.79 | $39K | 2026-06-01 | 高管卖出, 减持超20%持仓 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 1,094 | $36.87 | $40K | 2026-10-15 | C-suite卖出 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 2,906 | $37.61 | $109K | 2026-10-15 | C-suite卖出 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 4,000 | $33.99 | $136K | 2026-07-15 | C-suite卖出 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 1,101 | $25.24 | $28K | 2026-04-15 | C-suite卖出 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 2,573 | $23.76 | $61K | 2026-04-15 | C-suite卖出 |
| ★★★★★(15) | BHATT ELIZABETH | President and COO | 卖出 | 326 | $25.86 | $8K | 2026-04-15 | C-suite卖出 |
| ★★★★★(13) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 25,000 | $36.17 | $904K | 2026-06-22 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(12) | THIRD ROCK VENTURES V, L.P. | - | 卖出 | 141 | $51.08 | $7K | 2026-08-12 | 大股东(>10%)卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 10,001 | $39.13 | $391K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 12,592 | $39.13 | $493K | 2026-10-01 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 3,333 | $37.83 | $126K | 2026-09-01 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 2,334 | $34.68 | $81K | 2026-08-03 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 1,000 | $33.98 | $34K | 2026-08-03 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 1,233 | $34.81 | $43K | 2026-07-01 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 2,100 | $34.10 | $72K | 2026-07-01 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 7,000 | $35.97 | $252K | 2026-06-22 | 高管卖出 |
| ★★★★★(8) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 8,000 | $35.10 | $281K | 2026-06-22 | 高管卖出 |
| ★★★★★(8) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 8,428 | $34.03 | $287K | 2026-06-12 | 高管卖出 |
| ★★★★★(8) | BHATT ELIZABETH | - | 卖出 | 8,000 | $30.30 | $242K | 2026-02-18 | 高管卖出 |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 4,000 | $6.81 | $27K | 2026-10-15 | |
| ★★★★★(0) | PATNI RAJIV | Chief Medical Officer | 卖出 | 275,000 | - | - | 2026-09-08 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 3,333 | $2.76 | $9K | 2026-09-01 | |
| ★★★★★(0) | THIRD ROCK VENTURES V, L.P. | - | 卖出 | 0 | - | - | 2026-08-12 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 6,319 | $2.76 | $17K | 2026-08-11 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 18,681 | $6.81 | $127K | 2026-08-11 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 1,518 | - | - | 2026-08-03 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 1,816 | - | - | 2026-08-03 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 4,000 | - | - | 2026-07-15 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 3,333 | - | - | 2026-07-01 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 2,178 | - | - | 2026-06-29 | |
| ★★★★★(0) | GOTTESDIENER KEITH MICHAEL | - | 卖出 | 11,260 | - | - | 2026-06-26 | |
| ★★★★★(0) | EZEKOWITZ ALAN | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | RA CAPITAL MANAGEMENT, L.P. | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | SHARP SHALINI | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | SIMSON JAKE | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | COULIE BERNARD | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | TONG JEFFREY K | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | BASSAN ABRAHAM | - | 卖出 | 15,000 | - | - | 2026-06-26 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 10,529 | $2.76 | $29K | 2026-06-22 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 4,471 | $11.70 | $52K | 2026-06-22 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 6,250 | - | - | 2026-06-12 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 4,355 | $1.55 | $7K | 2026-06-01 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 943 | - | - | 2026-06-01 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 637 | $2.76 | $2K | 2026-06-01 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 11,798 | $6.81 | $80K | 2026-05-26 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 4,000 | $6.81 | $27K | 2026-04-15 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 5,101 | $2.76 | $14K | 2026-03-02 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 11,638 | $2.76 | $32K | 2026-03-02 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 53,714 | $1.55 | $83K | 2026-03-02 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 4,000 | - | - | 2026-02-18 | |
| ★★★★★(0) | LONG DANIEL D. | SVP, Drug Discovery | 卖出 | 80,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | KIM JAE B. | Chief Medical Officer | 卖出 | 125,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | LABRUCHERIE GIL M | Chief Financial Officer | 卖出 | 125,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | FINER JEFFREY | Chief Executive Officer | 卖出 | 400,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | KLEIN UWE | SVP, Biological Sciences | 卖出 | 80,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | BHATT ELIZABETH | President and COO | 卖出 | 155,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | WILSON MARK ANDREW | Chief Legal Officer | 卖出 | 165,000 | - | - | 2026-02-06 | |
| ★★★★★(0) | SHAIKHLY SAMIRA | Chief People Officer | 卖出 | 80,000 | - | - | 2026-02-06 |